Do we have enough evidence to use chloroquine/hydroxychloroquine as a public health panacea for COVID-19?
Vitória Andrade Palmeira, Larissa Braga Costa, Lucas Giandoni Perez, Victor Teatini Ribeiro, Katharina Lanza, Ana Cristina Simões e Silva
Abstract
The severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), a novel virus, was emerged in Wuhan, China, in December 2019. On March 11th, the World Health Organization (WHO) declared the outbreak of coronavirus disease 2019, and termed “COVID-19,” a pandemic. At that point, there were 118,000 confirmed cases and 4,291 victims worldwide (). Since then, researchers around the world have been analyzing the genetic structure, multiplication patterns and the cellular mechanisms of SARS-CoV-2 in vitro and in vivo to identify possible [...]
Topics & Concepts
Panacea (medicine)HydroxychloroquinePandemicCoronavirus disease 2019 (COVID-19)OutbreakPublic healthChloroquineCoronavirusSevere acute respiratory syndrome coronavirus 2 (SARS-CoV-2)Virology2019-20 coronavirus outbreakMedicineDiseaseIntensive care medicineMalariaImmunologyInfectious disease (medical specialty)PathologyAlternative medicineDrug-Induced Ocular ToxicityCOVID-19 Clinical Research StudiesInfectious Encephalopathies and Encephalitis